Literature DB >> 8445229

Absence or delayed appearance of hepatitis B core antibody in chronic hepatitis B surface antigen carrier children.

Y H Ni1, H Y Hsu, M H Chang, D S Chen, C Y Lee.   

Abstract

An absence of the hepatitis B core antibody (anti-HBc) in hepatitis B surface antigen (HBsAg) carrier children has been reported before, but whether anti-HBc will ultimately appear is unknown. In a group of 420 HBsAg carrier children who were followed longitudinally, 10 (2.4%) had an absence or delayed appearance of serum anti-HBc. These 10 children were persistently seropositive for HBsAg, hepatitis B e-antigen, and hepatitis B virus DNA (HBV-DNA). Anti-HBc never appeared in 4, one of whom was a case of hepatitis B vaccine failure and became an HBsAg carrier. Three of the 4 were born to HBsAg carrier mothers. Liver biopsy in one revealed non-specific reactive hepatitis (NSRH). All 4 were asymptomatic during follow-up. Mothers of the other 6 children who had delayed appearance of anti-HBc were also HBsAg carriers. The children seroconverted to anti-HBc positivity between 2 and 8 years of age, and the titer of serum anti-HBc at the first appearance varied. There were no significant changes in liver function tests, HBV-DNA levels, or associated symptoms and signs before and after seroconversion. Liver biopsies were performed before anti-HBc seroconversion in 2 children and showed NSRH. All 10 children had a moderate to high replication of HBV as shown by the high titer of HBsAg and HBV-DNA. The absence of anti-HBc occurred almost exclusively in children who were infected perinatally.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445229     DOI: 10.1016/s0168-8278(05)80030-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.

Authors:  V Avettand-Fenoel; D Thabut; C Katlama; T Poynard; V Thibault
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.

Authors:  Mary C Kuhns; Michael P Busch
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

4.  De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor.

Authors:  Harjot K Bedi; Roberto Trasolini; Christopher F Lowe; Trana Hussaini; Mark Bigham; Gordon Ritchie; Eric M Yoshida
Journal:  Hepatol Forum       Date:  2021-09-15

5.  Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene.

Authors:  Christophe M Olinger; Bernard Weber; Jesse A Otegbayo; Wim Ammerlaan; Natascha van der Taelem-Brulé; Claude P Muller
Journal:  Med Microbiol Immunol       Date:  2007-05-15       Impact factor: 3.402

Review 6.  Atypical serological profiles in hepatitis B virus infection.

Authors:  Robério A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.